RxDoctor Payments Data

Kristi Simpson, PA

Physician Assistant · Warren, PANPI 1104129873

Payments from drug & device makers

$1,404in general payments, 2019–2025

Across 72 payments — averaging $19.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$466
  • Pfizer$234
  • Johnson & Johnson$183
  • Sumitomo Pharma America, Inc.$155
  • Merck$151
  • AbbVie$83
  • plus $132 from 4 others

What the payments were for

  • Food & beverage$1,33995%
  • Education$655%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,404 in reported general payments places this provider in the 80th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$27,620
Medicare patients
246
Services billed
452

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron309$157,842
GemtesaVibegron60$27,812
Mirabegron ErMirabegron61$20,599
Trospium Chloride ErTrospium Chloride99$11,825
ElmironPentosan Polysulfate Sodium12$11,323
Solifenacin Succinate198$5,707
Vesicare LsSolifenacin Succinate11$5,260
Tamsulosin Hcl207$2,884
Trospium Chloride86$2,504
Tolterodine Tartrate ErTolterodine Tartrate45$2,015
Potassium Citrate ErPotassium Citrate15$1,858
Testosterone17$1,262
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst39$781
Cephalexin214$779
Oxybutynin Chloride ErOxybutynin Chloride49$540

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$466$157,842309 claims
Sumitomo Pharma America, Inc.Gemtesa$155$27,81260 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Warren

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →